Trillium
|
7
|
Zenith Epigenetics
|
Aug 23, 2021 01:03PM
|
Re: Zenith Email this morning
|
3
|
Zenith Epigenetics
|
Aug 17, 2021 08:26PM
|
Re: Zenith Email this morning
|
5
|
Zenith Epigenetics
|
Aug 17, 2021 10:19AM
|
Re: Shareholder Value
|
1
|
Zenith Epigenetics
|
Aug 07, 2021 01:43PM
|
Re: Shareholder Value
|
6
|
Zenith Epigenetics
|
Aug 07, 2021 01:41PM
|
Re: Idea for Zenith
|
4
|
Zenith Epigenetics
|
Jul 16, 2021 12:55PM
|
Re: Good Grief Charlie Brown….
|
2
|
Resverlogix Corp.
|
Jul 16, 2021 12:34PM
|
Re: No word on...
|
8
|
Resverlogix Corp.
|
Jul 13, 2021 04:57PM
|
Re: Ontario long-term care home grappling with worsening COVID-19 outbreak.
|
6
|
Resverlogix Corp.
|
Jul 05, 2021 01:10PM
|
Re: Last day of June.
|
11
|
Resverlogix Corp.
|
Jul 02, 2021 11:15AM
|
Re: Comments on today's annual update
|
8
|
Resverlogix Corp.
|
Jun 23, 2021 09:00AM
|
Re: Comments on today's annual update
|
9
|
Resverlogix Corp.
|
Jun 23, 2021 08:08AM
|
Re: Patience
|
4
|
Resverlogix Corp.
|
Jun 21, 2021 01:11PM
|
Re: U.S. to Invest $3 Billion on Developing Pills to Treat Covid
|
6
|
Resverlogix Corp.
|
Jun 18, 2021 12:12AM
|
Re: U.S. to Invest $3 Billion on Developing Pills to Treat Covid
|
5
|
Resverlogix Corp.
|
Jun 17, 2021 04:26PM
|
AGM link
|
11
|
Resverlogix Corp.
|
Jun 15, 2021 01:19PM
|
Re: AGM is in 1 week
|
10
|
Resverlogix Corp.
|
Jun 15, 2021 12:55PM
|
Re: Interesting read on the backlash to FDA's approval of aducanumab
|
6
|
Resverlogix Corp.
|
Jun 12, 2021 02:26PM
|
Financing May 12-17
|
2
|
Resverlogix Corp.
|
Jun 12, 2021 02:16PM
|
Re: US to shell out $1.2B for supplies of Merck's potential Covid-19 antiviral.
|
7
|
Resverlogix Corp.
|
Jun 10, 2021 06:20PM
|